Given the myriad of signaling pathways affected by PIK3CA, which include both AKT-dependent and -independent mechanisms [22,23,24,25,26], there is a need to phenotypically characterize the oncogenic readouts of non-hotspot mutations in more cancer hallmarks. This evidence concerns the gene AKT1 and cancer.